180 related articles for article (PubMed ID: 36814293)
1. Identification and validation of a novel prognostic signature based on mitochondria and oxidative stress related genes for glioblastoma.
Tong S; Xia M; Xu Y; Sun Q; Ye L; Yuan F; Wang Y; Cai J; Ye Z; Tian D
J Transl Med; 2023 Feb; 21(1):136. PubMed ID: 36814293
[TBL] [Abstract][Full Text] [Related]
2. The mitochondria-related gene risk mode revealed p66Shc as a prognostic mitochondria-related gene of glioblastoma.
Peng G; Feng Y; Wang X; Huang W; Li Y
Sci Rep; 2024 May; 14(1):11418. PubMed ID: 38763954
[TBL] [Abstract][Full Text] [Related]
3. Identification of SSBP1 as a ferroptosis-related biomarker of glioblastoma based on a novel mitochondria-related gene risk model and in vitro experiments.
Su J; Li Y; Liu Q; Peng G; Qin C; Li Y
J Transl Med; 2022 Sep; 20(1):440. PubMed ID: 36180956
[TBL] [Abstract][Full Text] [Related]
4. Immune cell infiltration and drug response in glioblastoma multiforme: insights from oxidative stress-related genes.
Wang K; Xiao Y; Zheng R; Cheng Y
Cancer Cell Int; 2024 Apr; 24(1):123. PubMed ID: 38566075
[TBL] [Abstract][Full Text] [Related]
5. Activated TRPA1 plays a therapeutic role in TMZ resistance in glioblastoma by altering mitochondrial dynamics.
Chen H; Li C; Hu H; Zhang B
BMC Mol Cell Biol; 2022 Aug; 23(1):38. PubMed ID: 35982414
[TBL] [Abstract][Full Text] [Related]
6. Dual-targeting of aberrant glucose metabolism in glioblastoma.
Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
[TBL] [Abstract][Full Text] [Related]
7. GRPEL2 Knockdown Exerts Redox Regulation in Glioblastoma.
Tang CT; Li YF; Chou CH; Huang LC; Huang SM; Hueng DY; Tsai CK; Chen YH
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884508
[TBL] [Abstract][Full Text] [Related]
8. Prognosis and Immune Landscapes in Glioblastoma Based on Gene-Signature Related to Reactive-Oxygen-Species.
Kaushal P; Zhu J; Wan Z; Chen H; Ye J; Luo C
Neuromolecular Med; 2023 Mar; 25(1):102-119. PubMed ID: 35779207
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
Bi Y; Wu ZH; Cao F
BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
[TBL] [Abstract][Full Text] [Related]
10. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
11. Identification of
Xia M; Tong S; Gao L
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255198
[TBL] [Abstract][Full Text] [Related]
12. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma.
Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G
Front Immunol; 2021; 12():706936. PubMed ID: 34899682
[TBL] [Abstract][Full Text] [Related]
13. Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses.
Ye S; Yang B; Zhang T; Wei W; Li Z; Chen J; Li X
Cells; 2022 Sep; 11(19):. PubMed ID: 36230961
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel glioblastoma multiforme molecular subtype with poor prognosis and high immune infiltration based on oxidative stress-related genes.
Huang G; Hou X; Li X; Yu Y; Ge X; Gan H
Medicine (Baltimore); 2024 Feb; 103(7):e35828. PubMed ID: 38363895
[TBL] [Abstract][Full Text] [Related]
15. Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways.
Bijangi-Vishehsaraei K; Reza Saadatzadeh M; Wang H; Nguyen A; Kamocka MM; Cai W; Cohen-Gadol AA; Halum SL; Sarkaria JN; Pollok KE; Safa AR
J Neurosurg; 2017 Dec; 127(6):1219-1230. PubMed ID: 28059653
[TBL] [Abstract][Full Text] [Related]
16. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
Lei CG; Jia XY; Sun WJ
Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species metabolism-based prediction model and drug for patients with recurrent glioblastoma.
Tan N; Liu J; Li P; Sun Z; Pan J; Zhao W
Aging (Albany NY); 2019 Dec; 11(23):11010-11029. PubMed ID: 31801111
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel glycolysis-related genes signature for isocitrate dehydrogenase 1-associated glioblastoma multiforme.
Cai X; Chen Z; Huang C; Shen J; Zeng W; Feng S; Liu Y; Li S; Chen M
Front Immunol; 2022; 13():950917. PubMed ID: 36389748
[TBL] [Abstract][Full Text] [Related]
19. Isoaaptamine increases ROS levels causing autophagy and mitochondria-mediated apoptosis in glioblastoma multiforme cells.
Wen ZH; Kuo HM; Shih PC; Hsu LC; Chuang JM; Chen NF; Sun HW; Liu HT; Sung CS; Chen WF
Biomed Pharmacother; 2023 Apr; 160():114359. PubMed ID: 36753955
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics.
Wang D; Jiang Y; Wang T; Wang Z; Zou F
BMC Med Genomics; 2022 May; 15(1):111. PubMed ID: 35550147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
